A novel transcatheter aortic valve with polymeric leaflets demonstrated favorable hemodynamic performance and an acceptable safety profile at 1 year in patients with aortic stenosis.
Does a novel transcatheter aortic valve with polymeric leaflets provide acceptable safety and hemodynamic performance in patients with aortic stenosis?
A novel transcatheter aortic valve with polymeric leaflets demonstrates early feasibility, acceptable safety, and favorable hemodynamics at 1 year for treating aortic stenosis.
Absolute Event Rate: 0% vs 0%
The preliminary outcomes of the novel transcatheter heart valve demonstrated a favorable hemodynamic performance with an acceptable safety profile at 1 year. Long-term follow-up is warranted to assess its durability in treating patients with AS.
Zhang et al. (Thu,) reported a other. A novel transcatheter aortic valve with polymeric leaflets demonstrated favorable hemodynamic performance and an acceptable safety profile at 1 year in patients with aortic stenosis.